MSD and Eisai’s trial saw mixed success with its two primary endpoints, seeing success in progression-free survival, but ...

Traws Pharma has completed the Phase I clinical trials of tivoxavir marboxil, a single-dose drug for treating or preventing ...

Medidata has announced the extension of its partnership of 13 years with Tigermed to enhance clinical trial processes.

The trial builds off the previous Phase Ia/II trial that saw an estimated survival rate of 52.4% at 24 months in patients ...

GlobalData epidemiologists forecast a rise in dementia cases in the US from 2.97 million in 2024 to 4.06 million by 2033.